Clinical utility of circulating tumor DNA (ctDNA) next generation sequencing (NGS) to inform treatment decisions for patients (pts) with advanced solid tumors

被引：0
|
作者：
Gomez Puerto, D. A. [1 ]
Rossi, A. [2 ]
Hernando Calvo, A. [1 ]
Ucha Hermida, J. M. [1 ]
Gomez, M. [3 ]
Matito, J. [3 ]
Vila-Casadesus, M. [3 ]
Morchon Araujo, D. [4 ]
Dienstmann, R. [5 ]
Galceran, J. C. [1 ]
Illescas, D. G. [1 ]
Macarulla Mercade, T. [1 ]
Garralda, E. [1 ]
Saura Manich, C. [1 ]
Elez Fernandez, M. E. [1 ]
Felip, E. [1 ]
Tabernero, J. [1 ]
Vivancos, A. [3 ]
机构：
[1] Vall dHebron Inst Oncol, Med Oncol Dept, Barcelona, Spain
[2] Azienda Osped Univ Integrata Verona, Med Oncol Dept, Verona, Italy
[3] VHIO Valle Hebron Inst Oncol, Genom Dept, Barcelona, Spain
[4] Univ Hosp Salamanca, Med Oncol Dept, Salamanca, Spain
[5] Vall dHebron Inst Oncol, Oncol Data Sci Dept, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.135
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
127P
引用
收藏
页码：S265 / S266
页数：2
相关论文
共 50 条
  • [1] Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Keane, Fergus
    Saadat, Lily
    O'Connor, Catherine
    Chou, Joanne F.
    Brannon, Angela Rose
    Cowzer, Darren
    Crowley, Fionnuala
    Debnath, Neha
    Bowman, Anita
    Xu, Fei
    Park, Wungki
    Zervoudakis, Alice
    Balogun, Fiyinfolu
    Varghese, Anna M.
    Yu, Kenneth H.
    Kelsen, David Paul
    Capanu, Marinela
    Berger, Michael F.
    Wei, Alice Chia-Chi
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Clinical utility of tumor next-generational sequencing (NGS) panel testing to inform treatment decisions for patients with advanced solid tumors.
    Bogdan, Lucia
    Saleh, Ramy R.
    Avery, Lisa
    Del Rossi, Samanta
    Yu, Celeste
    Bedard, Philippe L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Clinical Utility of Tumor Next-Generation Sequencing Panel Testing to Inform Treatment Decisions for Patients With Advanced Solid Tumors in a Tertiary Care Center
    Bogdan, Lucia
    Saleh, Ramy R.
    Avery, Lisa
    Del Rossi, Samanta
    Yu, Celeste
    Bedard, Philippe L.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [4] Circulating tumor DNA (ctDNA) next generation sequencing (NGS): Molecular prescreening for tailoring treatment in clinical trials
    Alonso, G.
    Aguilar, S.
    Ros Montana, F. J.
    Verdaguer, H.
    Callejo Perez, A.
    Brana, I.
    Baraibar Argota, I.
    Iranzo Gomez, P.
    Santa Gadea, O. Saavedra
    Salva Ballabrera, F.
    Acosta Eyzaguirre, D. A.
    Vieito Villar, M.
    Garcia Torralba, E.
    Wornham, N. A.
    Faull, I.
    Tabernero, J.
    Felip, E.
    Elez, E.
    Macarulla Mercade, T.
    Garralda, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S1346 - S1348
  • [5] Next generation sequencing of solid tumor and circulating tumor DNA (ctDNA) in metastatic melanoma
    Carpenter, Erica L.
    Yee, Stephanie S.
    Soucier, Devon
    Morrissette, Jennifer J.
    Xu, Wei
    Harmon, Shannon R.
    Salathia, Neeraj
    Zhao, Yue
    Waters, Jill
    Fan, Jian-Bing
    Schuchter, Lynn Mara
    Amaravadi, Ravi K.
    Karakousis, Giorgos Constantine
    Gangadhar, Tara C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Clinical Utility of Circulating Tumor DNA (ctDNA) Analysis by Digital next Generation SequenCing of over 5,000 Advanced NSCLC Patients
    Mack, Philipp
    Banks, Kimberly
    Riess, Jonathan
    Zil, Oliver
    Mortimer, Stefanie
    Chudova, Darya
    Odegaard, Justin
    Lee, Christine
    Nagy, Rebecca
    Eltoukhy, Helmy
    Talasaz, Amirali
    Lanman, Richard
    Gandara, David R.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S263 - S264
  • [7] advanced prostate cancer (aPC) using machine learning and next-generation sequencing (NGS) of circulating tumor DNA (ctDNA).
    Lin, Edwin
    Hahn, Andrew W.
    Sonpavde, Guru
    Lilly, Michael B.
    Nussenzveig, Roberto
    Ledet, Elisa
    Pal, Sumanta K.
    Grivas, Petros
    Rich, Thereasa A.
    Raymond, Victoria M.
    Sartor, A. Oliver
    Yandell, Mark
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [8] Biomarker analysis by next generation circulating tumor DNA (ctDNA) sequencing in patients with advanced breast cancer
    Li, Huiping
    Wang, Jing
    Rugo, Hope S.
    Zhang, Yan
    Yang, Ling
    Liu, Xiaoran
    Shao, Bin
    Xu, Yaping
    Yang, Liang
    Zhang, Ruyan
    Ran, Ran
    Chang, Lianpeng
    CANCER RESEARCH, 2018, 78 (04)
  • [9] Utility of circulating tumor DNA (ctDNA) to inform treatment of patients with metastatic breast cancer
    Linville, Laura Meili
    Canzoniero, Jenna VanLiere
    Too, Faith
    Lombardo, Alexandra
    Malwankar, Jui
    Mawalkar, Resham
    Haile, Meron
    Zandi, Lily
    Babu, Vidya
    Brown, Derek W.
    Xu, Chang
    Boyle, Patrick
    Pasquina, Lincoln W.
    Santa-Maria, Cesar Augusto
    Tao, Jessica
    Bayable, Asnakech
    Greenberg, Larisa
    Anagnostou, Valsamo
    Stearns, Vered
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Genomic alterations in 670 patients with diverse cancers analyzed by next-generation sequencing (NGS) of circulating tumor DNA (ctDNA).
    Schwaederle, Maria Clemence
    Chattopadhyay, Ranajoy
    Kato, Shumei
    Fanta, Paul T.
    Banks, Kimberly
    Piccioni, David Eric
    Ikeda, Sadakatsu
    Talasaz, AmirAli
    Lanman, Richard B.
    Bazhenova, Lyudmila
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345